An Ba Huisong Izinin Ƙirƙirar Ƙirƙirar Haƙƙin mallaka mai alaƙa da Yuxingcao Qinlan Heji

A ranar 3 ga Nuwamba, 2023, Zhejiang Huisong Pharmaceuticals Co., Ltd. an ba shi izinin ƙirƙira ikon ƙirƙira don hanyar tantance ƙididdiga na nucleosides a Yuxingcao Qinlan Heji Intermediate. Ƙirƙirar tana bayyana hanya don ƙididdige ƙimar nucleosides a cikin Yuxingcao Qinlan Heji Intermediate. Nucleosides na tsaka-tsakin sun hada da uridine da guanosine.
1) Shirya maganin gwajin tare da Yuxingcao Qinlan Heji Intermediate. Shirya maganin magana ta amfani da ma'auni na uridine da ma'aunin ma'aunin guanosin.
2) Yi bincike na chromatography na ruwa akan maganin tunani da maganin gwajin, da kuma shirya Waters Atlantis T3 a matsayin shafi na chromatographic; Yi amfani da ruwa azaman lokacin wayar hannu A da acetonitrile azaman lokacin wayar hannu B don haɓakar gradient.
3) Yi rikodin chromatogram, ƙididdigewa ta wurin kololuwar yanki don biyan daidaitattun hanyar waje don tantance abun ciki na nucleosides a cikin maganin gwaji.
Wannan hanya, wanda ke da halaye na ɗan gajeren lokaci na bincike, ƙananan buƙatun kayan aiki, tsari mai sauƙi, tare da ingantaccen sakamako mai dogara, zai iya cika rata a cikin fasahar da ake ciki a cikin kula da ingancin kayan aiki na magani da tsaka-tsaki.